Carson Wealth (CWM LLC)’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
BBA
RI
ACA
PC
Carson Wealth (CWM LLC)'s MDGL Position: Q1 2026 in Review
Carson Wealth (CWM LLC) increased its Madrigal Pharmaceuticals (MDGL) stake by 8.6% in Q1 2026, buying an estimated $77.4K and bringing the position to 2,037 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #1499.
Carson Wealth (CWM LLC) first reported a position in MDGL in Q4 2018 and has held it in 19 quarters since. The position peaked at $1.09M in Q4 2025. 380 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.
- Carson Wealth (CWM LLC) held 2,037 shares of Madrigal Pharmaceuticals worth $1.07M as of Q1 2026.
- Carson Wealth (CWM LLC) bought 162 Madrigal Pharmaceuticals shares in Q1 2026, an estimated $77.4K.
- Madrigal Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #1499 holding.
- Carson Wealth (CWM LLC) first reported a position in Madrigal Pharmaceuticals in Q4 2018 and has held it in 19 quarters since.
- Carson Wealth (CWM LLC)'s Madrigal Pharmaceuticals position peaked at $1.09M in Q4 2025.
- 380 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.